Planning Strategies’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.45K Buy
33
+1
+3% +$212 ﹤0.01% 378
2026
Q2
$6.91K Buy
+32
New +$6.12K ﹤0.01% 380

Other funds holding BIIB

Planning Strategies's BIIB Position: Q3 2026 in Review

Planning Strategies increased its Biogen (BIIB) stake by 3.1% in Q3 2026, buying an estimated $212 and bringing the position to 33 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Planning Strategies first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Planning Strategies held 33 shares of Biogen worth $7.45K as of Q3 2026.
  • Planning Strategies bought 1 Biogen share in Q3 2026, an estimated $212.
  • Biogen made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #378 holding.
  • Planning Strategies first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.